Abbott Laboratories fell just short of Wall Street estimates for quarterly reven...
) fell just short of Wall Street estimates for quarterly revenue on Wednesday, as weakness in the medical device maker’s cardiovascular business overshadowed strong performance in its fast-growing diabetes care unit.
Shares of the company, which also trimmed its full-year profit forecast, flitted between gains and losses. They were last up about 1.7%, after having risen about 13% to Tuesday’s close. A 63% jump in sales of FreeStyle Libre continuous glucose monitor powered the diabetes unit’s better-than-expected revenue of $665 million. Two analysts polled by Refinitiv had expected $645 million.
The cardiovascular business, the company’s biggest that houses the MitraClip, posted sales of $2.40 billion, below estimates of $2.44 billion, according to two analysts polled by Refinitiv.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
‘Jojo Rabbit’ Review: A Hit-or-Miss Hitler Comedy With a HeartLove it or hate it, JojoRabbit — Taika Waititi's singular, silly take on WWII coming-of-age movies—is impossible to shake, says Peter Travers
続きを読む »
J&J beats third-quarter earnings expectations on higher prescription drug salesJ&J's pharmaceutical business, which accounts for half of the company's revenue, posted revenue of $10.88 billion.
続きを読む »
Amazon is eating into Google's dominance in search adsAmazon's search ad revenue is climbing as many consumers search for products on the platform.
続きを読む »
Consumer banking powers Citigroup's profit beatCitigroup Inc beat analysts' estimates for quarterly revenue and profit on ...
続きを読む »
Huawei's third-quarter revenue jumps 27% as smartphone sales surgeHuawei, the world’s largest telecommunications equipment maker, reported a 27% jump in third-quarter revenue, thanks to a surge in smartphones it shipped before a U.S. trade blacklisting
続きを読む »